Literature DB >> 32166855

Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?

Fred K L Spijkervet1, Jennifer M Schuurhuis1, Monique A Stokman2, Max J H Witjes1, Arjan Vissink1.   

Abstract

Pretreatment dental screening aims to locate and eliminate oral foci of infection in order to eliminate local, loco-regional, or systemic complications during and after oncologic treatment. An oral focus of infection is a pathologic process in the oral cavity that does not cause major infectious problems in healthy individuals, but may lead to severe local or systemic inflammation in patients subjected to oncologic treatment. As head and neck radiotherapy patients bear a lifelong risk on oral sequelae resulting from this therapy, the effects of chemotherapy on healthy oral tissues are essentially temporary and reversible. This has a large impact on what to consider as an oral focus of infection when patients are subjected to, for example, head and neck radiotherapy for cancer or intensive chemotherapy for hematological disorders. While in patients subjected to head and neck radiotherapy oral foci of infection have to be removed before therapy that may cause problems ultimately, in patients that will receive chemotherapy such, so-called chronic, foci of infection are not in need of removal of teeth but can be treated during a remission phase. Acute foci of infection always have to be removed before or early after the onset of any oncologic treatment.
© 2020 The Authors. Oral Diseases published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chemotherapy; head and neck oncology; hematology; oral foci of infection; radiotherapy; teeth

Mesh:

Year:  2020        PMID: 32166855      PMCID: PMC7818265          DOI: 10.1111/odi.13329

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  43 in total

Review 1.  Risk factors for osteoradionecrosis after head and neck radiation: a systematic review.

Authors:  Syed Nabil; Nabil Samman
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-02-03

Review 2.  Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy.

Authors:  J Jansma; A Vissink; F K Spijkervet; J L Roodenburg; A K Panders; A Vermey; B G Szabó; E J Gravenmade
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

Review 3.  IMRT: a review and preview.

Authors:  Thomas Bortfeld
Journal:  Phys Med Biol       Date:  2006-06-20       Impact factor: 3.609

Review 4.  Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.

Authors:  Siri Beier Jensen; Arjan Vissink; Kirsten H Limesand; Mary E Reyland
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 5.  Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.

Authors:  K Hull; I Kerridge; S Avery; M McCullough; D Ritchie; J Szer
Journal:  Intern Med J       Date:  2015-07       Impact factor: 2.048

Review 6.  Research Frontiers in Oral Toxicities of Cancer Therapies: Osteoradionecrosis of the Jaws.

Authors:  Frederik K L Spijkervet; Michael T Brennan; Douglas E Peterson; Max J H Witjes; Arjan Vissink
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

7.  Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation.

Authors:  Ahmed S Sultan; Yvette Zimering; Gloria Petruzziello; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Vincent T Ho; Stephen T Sonis; Sook-Bin Woo; Francisco M Marty; Nathaniel S Treister
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-06-16

8.  A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation.

Authors:  K Yamagata; K Onizawa; T Yanagawa; Y Hasegawa; H Kojima; T Nagasawa; H Yoshida
Journal:  Bone Marrow Transplant       Date:  2006-08       Impact factor: 5.483

Review 9.  Current ideas to reduce or salvage radiation damage to salivary glands.

Authors:  A Vissink; P van Luijk; J A Langendijk; R P Coppes
Journal:  Oral Dis       Date:  2014-02-28       Impact factor: 3.511

Review 10.  Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?

Authors:  Fred K L Spijkervet; Jennifer M Schuurhuis; Monique A Stokman; Max J H Witjes; Arjan Vissink
Journal:  Oral Dis       Date:  2020-06-01       Impact factor: 3.511

View more
  8 in total

1.  FDG-PET/CT for oral focus assessment in head and neck cancer patients.

Authors:  Dominic Raphael Schwaninger; Martin Hüllner; Dominique Bichsel; Barbara Giacomelli-Hiestand; Nicole Selina Stutzmann; Panagiotis Balermpas; Silvio Valdec; Bernd Stadlinger
Journal:  Clin Oral Investig       Date:  2022-03-07       Impact factor: 3.606

2.  Prosthodontic rehabilitation of head and neck cancer patients-Challenges and new developments.

Authors:  Nathalie Vosselman; Jamie Alberga; Max H J Witjes; Gerry M Raghoebar; Harry Reintsema; Arjan Vissink; Anke Korfage
Journal:  Oral Dis       Date:  2020-05-26       Impact factor: 3.511

Review 3.  Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?

Authors:  Fred K L Spijkervet; Jennifer M Schuurhuis; Monique A Stokman; Max J H Witjes; Arjan Vissink
Journal:  Oral Dis       Date:  2020-06-01       Impact factor: 3.511

4.  Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients-A Feasibility Study.

Authors:  Silvio Valdec; Fabienne A Bosshard; Martin Hüllner; Dominic R Schwaninger; Larissa Stocker; Barbara Giacomelli-Hiestand; Bernd Stadlinger
Journal:  Front Med (Lausanne)       Date:  2022-03-21

5.  One Third of Patients before Endoprosthesis Implantation Show an Oral Focus as Potential Source of Infectious Complication-The Value of Pre-Operative Dental Risk Stratification in a German Cohort.

Authors:  Gerhard Schmalz; Florentine Reuschel; Markus Bartl; Laura Schmidt; Janine Runge; Rainer Haak; Szymon Goralski; Andreas Roth; Dirk Ziebolz
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

6.  The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Alexa M G A Laheij; Anneke M Westermann; Jan de Lange; Ludi E Smeele
Journal:  Front Oral Health       Date:  2022-06-30

Review 7.  What is the optimal timing for implant placement in oral cancer patients? A scoping literature review.

Authors:  Jamie M Alberga; Nathalie Vosselman; Anke Korfage; Konstantina Delli; Max J H Witjes; Gerry M Raghoebar; Arjan Vissink
Journal:  Oral Dis       Date:  2020-03-19       Impact factor: 3.511

8.  Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.

Authors:  Doke J M Buurman; Anna C H Willemsen; Caroline M Speksnijder; Laura W J Baijens; Ann Hoeben; Frank J P Hoebers; Peter Kessler; Annemie M W J Schols
Journal:  Support Care Cancer       Date:  2022-03-12       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.